Randomised Clinical Trial
Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation
Article first published online: 4 MAR 2013
© 2013 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 37, Issue 8, pages 776–785, April 2013
How to Cite
Aliment Pharmacol Ther 2013; 37: 776–785
- Issue published online: 18 MAR 2013
- Article first published online: 4 MAR 2013
- Manuscript Accepted: 5 FEB 2013
- Manuscript Revised: 4 FEB 2013
- Manuscript Revised: 29 JAN 2013
- Manuscript Received: 17 JAN 2013
- Clinical Research Unit of the Mayo Clinic. Grant Number: UL1 TR000135
|apt12264-sup-0001-Table S1-3.docx||Word document||16K|
Table S1. Statistical power.
Table S2. Treatment effects of TU-100 on quality of life. There were no significant overall differences in quality of life or any of the quality of life indices between groups.
Table S3. Adverse events affecting at least 2 participants in any group. TU-100 was safe and well tolerated throughout the study. Overall, there were no significant differences between groups for any of the observed adverse events.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.